Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Xyrem
Xyrem
Jazz looks at strategic options, including possible sale or unit divestiture
Fierce Pharma
Fri, 10/20/23 - 11:58 am
Jazz Pharma
Xyrem
M&A
Jazz Pharma sues FDA over approval of rival narcolepsy drug
Medical Marketing and Media
Tue, 06/27/23 - 11:29 am
Jazz Pharma
FDA
Xyrem
Avadel Pharma
Lumryz
legal
Jazz brings the noise to the FDA with lawsuit over approval of Avadel's narcolepsy drug Lumryz
Fierce Pharma
Sun, 06/25/23 - 09:41 pm
Jazz Pharmaceuticals
FDA
legal
Avadel Pharmaceuticals
Lumryz
Xyrem
With FDA nod for Lumryz, Avadel is set to Jazz up the narcolepsy market
Fierce Pharma
Tue, 05/2/23 - 11:41 am
Avadel Pharma
Jazz Pharma
Lumryz
Xyrem
narcolepsy
Federal Circuit court halts delisting of Jazz narcolepsy drug patent from the Orange Book
Endpoints
Thu, 12/15/22 - 11:04 pm
legal
Orange Book
Jazz Pharma
FDA
patents
narcolepsy
Xyrem
In Jazz case, FTC urges court to delist patent on blockbuster Xyrem
Fierce Pharma
Mon, 11/14/22 - 10:55 am
Jazz Pharma
FTC
Xyrem
narcolepsy
legal
Avadel gets tentative FDA nod for rival to Jazz narcolepsy drug
Fierce Pharma
Tue, 07/26/22 - 11:25 am
Avadel
Jazz Pharma
narcolepsy
Xyrem
Lumryz
Upcoming events – Avadel takes on Jazz and Axovant awaits early results
EP Vantage
Fri, 02/14/20 - 10:35 am
Avadel
FT218
Jazz Pharmaceuticals
Xyrem
Axovant
gene therapy
Parkinson's Disease
narcolepsy
As investors fret about Xyrem durability, Jazz spends $52M+ upfront to swallow neuro-focused biotech
Endpoints
Wed, 08/14/19 - 10:19 am
Jazz Pharma
Xyrem
Cavion
M&A
Jazz's narcolepsy treatment passes Phase 3 test
Biopharma Dive
Wed, 03/27/19 - 11:39 am
Jazz Pharmaceuticals
narcolepsy
JZP-258
Xyrem
U.S. court denies Jazz Pharma bid to revive narcolepsy drug patents
Reuters
Sat, 07/14/18 - 01:31 pm
Jazz Pharmaceuticals
narcolepsy
Xyrem
Amneal
generics
3 Reasons Jazz Pharmaceuticals Stock Could Fall
Motley Fool
Sun, 06/18/17 - 11:38 pm
Jazz Pharmaceuticals
Vyxeos
Xyrem
Jazz Pharmaceuticals stock surges 7% on settlement with Hikma over generic drug
Marketwatch
Thu, 04/6/17 - 09:36 am
Jazz Pharmaceuticals
Hikma
generics
Xyrem
narcolepsy
Top 25 rare disease brands, by sales
Medical Marketing and Media
Wed, 02/15/17 - 11:20 am
rare disease
Copaxone
Teva Pharmaceutical
Avonex
Biogen
Sensipar
Soliris
Alexion
Xyrem
Jazz Pharmaceuticals
FDA approves generic version of Jazz Pharma's sleep disorder drug
Yahoo/Reuters
Tue, 01/17/17 - 10:10 pm
FDA
generics
Jazz Pharmaceuticals
Xyrem
narcolepsy
Jazz Pharma Could Be Worth Over $200 If Xyrem Adds Long-Term Value: Here's How
Yahoo/Benzinga
Fri, 07/31/15 - 03:12 pm
Jazz Pharmaceuticals
Xyrem
Jazz Pharmaceuticals (JAZZ) Starts Late-Stage Study on Xyrem
Yahoo/Zacks.com
Wed, 12/3/14 - 09:40 am
Jazz Pharmaceuticals
Xyrem
narcolepsy
The top 10 most expensive drugs of 2013
Fierce Pharma
Tue, 10/14/14 - 10:05 am
drug pricing
Soliris
Alexion
Naglazyme
Biomarin
Kalydeco
Vertex
Cinryze
Shire
Sprycel
Bristol-Myers Squibb
Pomalyst
Celgene
Xyrem
Jazz Pharmaceuticals
Erbitux
Merck KGaA
Revlimid
Questcor
Mallinckrodt
H.P. Acthar Gel
10 big brands keep pumping out big bucks, with a little help from price hikes
Fierce Pharma Marketing
Wed, 05/7/14 - 03:42 pm
Xyrem
Jazz Pharmaceuticals
Humulin
Eli Lilly
Premarin
Mylan
Lunesta
Sunovion
Benicar
Daiichi Sankyo
Lantus
Sanofi
Viagra
Pfizer
Gleevec
Novartis
Copaxone
Teva Pharmaceuticals
EpiPen
drug pricing
Jazz Shares Gain Most in More Than 3 Months on Financial Expectations
Bloomberg
Thu, 01/5/12 - 10:02 am
Xyrem
Jazz Pharmaceuticals
Azur Pharma
Pages
1
2
next ›
last »